marijuana stocks

Form 8-K for LEXARIA CORP.


22-Jul-2015

Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial Stateme

Item 3.02 Unregistered Sales of Equity SecuritiesOn July 22, 2015, the Company issued 500,000 common shares $0.17 per share to Docherty Management, wholly owned company by the President of the Company pursuant to the terms of the consulting agreement signed on March 26, 2015.

The Company issued the units to one (1) non-US persons in an off-shore transaction pursuant to the exemption from registration provided for under Regulation S, promulgated under the United States Securities Act of 1933, as amended. Each of the subscribers represented that they were not a “US person” as such term is defined in Regulation S.

The securities referred to herein will not be and have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

 

Item 7.01 Regulation FD Disclosure.A copy of the news release announcing the share issuance is filed as exhibit 99.1 to this current report and is hereby incorporated by reference.

 

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.(d) Exhibits.

Exhibit No. Description

99.1 Press Release dated July 22, 2015


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$INCC Shareholder Update on St. James Remedies (SJR) Part 2

International Consolidated Companies (OTC: INCC) Shareholder Update on St. James Remedies (SJR)…

American Green (ERBB) Projects Continued Growth and Profitability

American Green Projects Continued Growth and Profitability for its Online and Wholesale…

Tilray Brands, Inc. (TLRY) Celebrates Six Years of Cannabis Legalization in Canada

Tilray Brands Celebrates Six Years of Cannabis Legalization in Canada with Industry-Leading…

$PDLI Completes Royalty Transaction with ARIAD Pharmaceuticals

PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals  PDL BioPharma, Inc. (PDLI)…